Daniela Arduini, Chiara Ciccarese, Alessandro Acunzo, Matteo Perrino, Marco Maruzzo, Elena Verzoni, Caterina Accettura, Lucia Bonomi, Consuelo Buttigliero, Malvina Cremante, Stefania Pipitone, Mario Scartozzi, Cristina Masini, Veronica Mollica, Francesca Primi, Alessandro Strusi, Sebastiano Buti, Paolo Andrea Zucali, Emanuela Fantinel, Roberto Iacovelli. "Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.551